Literature DB >> 2260965

Transformation by ras oncogene induces nuclear shift of protein kinase C.

V Chiarugi1, L Magnelli, F Pasquali, S Vannucchi, P Bruni, A Quattrone, G Basi, S Capaccioli, M Ruggiero.   

Abstract

We measured protein kinase C (PKC) activity in normal and ras-transformed Balb/3T3 fibroblasts; cytosolic and nuclear-associated PKC activity was determined either as phorbol ester binding, PKC-dependent phosphorylation of histone III-S, or phosphorylation of endogenous nuclear proteins. Results demonstrate that ras-transformed fibroblasts show down-regulation of cytosolic PKC accompanied by increase of nuclear-associated PKC. These results provide evidence linking transformation to PKC nuclear shift with consequent phosphorylation of nuclear proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2260965     DOI: 10.1016/s0006-291x(05)80066-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Transcriptional activation of c-fos by oncogenic Ha-Ras in mouse mammary epithelial cells requires the combined activities of PKC-lambda, epsilon and zeta.

Authors:  S Kampfer; K Hellbert; A Villunger; W Doppler; G Baier; H H Grunicke; F Uberall
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

2.  Phosphorylation of cardiac junctional and free sarcoplasmic reticulum by PKC alpha, PKC beta, PKA and the Ca2+/calmodulin-dependent protein kinase.

Authors:  B G Allen; S Katz
Journal:  Mol Cell Biochem       Date:  1996-02-23       Impact factor: 3.396

3.  Protein kinase Czeta attenuates hypoxia-induced proliferation of fibroblasts by regulating MAP kinase phosphatase-1 expression.

Authors:  Megan D Short; Stephanie M Fox; Ching F Lam; Kurt R Stenmark; Mita Das
Journal:  Mol Biol Cell       Date:  2006-02-08       Impact factor: 4.138

4.  PIK1, an essential phosphatidylinositol 4-kinase associated with the yeast nucleus.

Authors:  J F Garcia-Bustos; F Marini; I Stevenson; C Frei; M N Hall
Journal:  EMBO J       Date:  1994-05-15       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.